×
Please click
here
if you are not redirected within a few seconds.
All
News
Images
Maps
Videos
Shopping
Books
Search tools
Recent
Recent
Past hour
Past 24 hours
Past week
Past month
Past year
Archives
Sorted by relevance
Sorted by relevance
Sorted by date
EyePoint Pharmaceuticals (EYPT) Soars 21.6%: Is Further Upside Left in the Stock?
Yahoo Lifestyle Canada
EyePoint Pharmaceuticals (EYPT) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate...
5 hours ago
EyePoint’s stock plunges as eye treatment fails to meet trial goal
MarketWatch
Shares of EyePoint Pharmaceuticals dropped nearly 30% premarket on Monday after the company said its experimental eye disease treatment...
3 weeks ago
EyePoint Pharmaceuticals's cGMP Manufacturing Facility, USA
Pharmaceutical Technology
Expected Completion · The facility is set to be operational in 2024. · EyePoint Pharmaceuticals's cGMP manufacturing facility will be built in...
2 months ago
Victory Capital Management Inc. Invests $659000 in EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT)
Defense World
Read Victory Capital Management Inc. Invests $659000 in EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT) at Defense World.
1 day ago
EyePoint reports Duravyu trial fail, raising questions
Fierce Pharma
Targeting a major market in retinal diseases, EyePoint has revealed that its lead candidate failed to meet its primary endpoint in a phase 2...
3 weeks ago
EyePoint Pharmaceuticals: Q1 Earnings Snapshot
The Washington Post
WATERTOWN, Mass. — WATERTOWN, Mass. — EyePoint Pharmaceuticals (EYPT) on Wednesday reported a loss of $29.3 million in its first quarter.
2 weeks ago
Readout Newsletter: Merck, Pfizer, EyePoint, and more
STAT
Today's biotech news updates include Amgen's weight loss drug MariTide, a former Spark CTO's lawsuit, and Pfizer's new hire.
3 weeks ago
Deep Dive Into EyePoint Pharmaceuticals Stock: Analyst Perspectives (4 Ratings)
markets.businessinsider.com
4 analysts have expressed a variety of opinions on EyePoint Pharmaceuticals (NASDAQ:EYPT) over the past quarter, offering a diverse set of...
2 weeks ago
EyePoint Pharmaceuticals First Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
Simply Wall Street
EyePoint Pharmaceuticals ( NASDAQ:EYPT ) First Quarter 2024 Results Key Financial Results Revenue: US$11.7m (up 52...
2 weeks ago
Why Is EyePoint Pharmaceuticals Stock Plummeting On Monday?
Yahoo Finance
On Monday, EyePoint Pharmaceuticals Inc. (NASDAQ:EYPT) announced the topline results of its Phase 2 PAVIA trial evaluating Duravyu...
3 weeks ago